Central Florida Sports Medicine Institut is categorized under Sports Medicines in Orlando, FL and active since 2001.
Central Florida Sports Medicine Institut was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Sports Medicines business, which does work in the B2C market, and is classified as a Sports Medicines, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact David Lucas at the company’s single location by writing to 77 West Underwood St # 100, Orlando, Florida FL 32806 or by phoning (407) 649-6500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Central Florida Sports Medicine Institut |
Contact Person: | David Lucas |
Address: | 77 West Underwood St # 100, Orlando, Florida 32806 |
Phone Number: | (407) 649-6500 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Sports Medicines |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Central Florida Sports Medicine Institut was started in 2001 to provide professional Sports Medicines under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact David Lucas for inquiries that concern Central Florida Sports Medicine Institut by calling the company number (407) 649-6500, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Florida Sports Medicine Institut can be found at the coordinates as well as the street address 77 West Underwood St # 100 in Orlando, Florida 32806.
For its online presence, you may visit Central Florida Sports Medicine Institut’s website at and engage with its social media outlets through on Twitter and on Facebook.